COVID-19 UPDATE

Contact

BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

Events & Presentations

Past Events

BioDelivery Sciences International Investor Day

Oct 14, 2021 at 10:30 AM EDT

Listen to webcast

Cantor Fitzgerald Global Healthcare Conference

Sep 28, 2021 at 9:20 AM EDT

Listen to webcast

H.C. Wainwright 23rd Annual Global Investment Conference

Sep 13, 2021 at 7:00 AM EDT

August Investor Presentation

Aug 9, 2021

Supporting Materials

View Presentation 2.2 MB

BDSI Second Quarter 2021 Financial Results Call and Webcast

Aug 4, 2021 at 8:30 AM EDT

Listen to webcast

Supporting Materials

View Presentation 1.5 MB

BDSI First Quarter 2021 Financial Results Call and Webcast

May 6, 2021 at 8:30 AM EDT

Listen to webcast

Supporting Materials

View Presentation 622.2 KB

BDSI Fourth Quarter 2020 Financial Results Call and Webcast

Mar 10, 2021 at 8:30 AM EST

Listen to webcast

Supporting Materials

View Presentation 751.1 KB

Piper Sandler 32nd Annual Healthcare Conference

Nov 23, 2020

Southwest IDEAS Investor Conference

Nov 18, 2020 at 8:00 AM EST

Listen to webcast

Recent BDSI News

BioDelivery Sciences International to Host ELYXYB™ Investor Day September 30, 2021

The First and Only FDA-Approved, Ready-to-Use Oral Solution for the Acute Treatment of Migraine with or without Aura in Adults Virtual Event on October 14, 2021 RALEIGH, N.C. , Sept. 30, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a growing specialty ...

BioDelivery Sciences International Completes Acquisition of ELYXYB™ for Acute Migraine Treatment in the U.S. and Canada September 9, 2021

Expands Portfolio and Establishes Growth Platform in Neurology The First and Only FDA-Approved, Ready-to-Use Oral Solution for the Acute Treatment of Migraine with or without Aura in Adults Commercial Launch Planned for Q1 2022 Investor Day on October 14, 2021 RALEIGH, N.C. , Sept. ...

BioDelivery Sciences to Exhibit Three Scientific Posters Comparing BELBUCA® to Oxycodone at the PAINWeek 2021 Conference September 7, 2021

RALEIGH, N.C. , Sept. 07, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a growing specialty pharmaceutical company dedicated to patients living with chronic conditions, will showcase three scientific posters regarding BELBUCA ® (buprenorphine buccal film), CIII ...

More news

More events

Stay Connected

Stay up to date on the latest news

Get started now